Cost-effectiveness analysis comparing QuantiFERON test and tuberculin skin test for the diagnosis of latent tuberculosis infection in immunocompetent children under 15 years of age in Colombia
Objective To determine the cost-effectiveness of the QuantiFERON (QFT) test versus the tuberculin skin test (TST) in diagnosing latent tuberculosis infection (LTBI) in immunocompetent children under 15 years of age who are in contact with active tuberculosis (TB) patients in the context of the Colom...
Saved in:
| Main Authors: | Ivan D Florez, Dione Benjumea-Bedoya, Andrés Felipe Estupiñán-Bohorquez, Cristian Eduardo Navarro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-03-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/3/e087333.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.
by: Kwame Shanaube, et al.
Published: (2011-04-01) -
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.
by: Chuan-Yu Hsiao, et al.
Published: (2017-01-01) -
QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients
by: Zehra Ozsoy, et al.
Published: (2025-05-01) -
Comparison between the Interferon γ Release Assay—QuantiFERON Gold Plus (QFT-Plus)—and Tuberculin Skin Test (TST) in the Detection of Tuberculosis Infection in Immunocompromised Children
by: Cory Primaturia, et al.
Published: (2020-01-01) -
Factors associated with indeterminate QuantiFERON-TB Gold Plus Test results during the COVID-19 pandemic
by: Carla M. Román-Montes, et al.
Published: (2025-01-01)